DEA proposes classifying three kratom-related substances as Schedule I drugs
/ 1 min read
Table of Contents
The Drug Enforcement Administration (DEA) has issued a notice of intent to temporarily move three specific chemicals—mitragynine pseudoindoxyl, MGM-15, and MGM-16—into Schedule I. These are derivatives related to 7-hydroxymitragynine, a compound found in the kratom plant.
Why it matters: This is a regulatory action that would make it much harder for researchers or manufacturers to handle these specific chemical derivatives by requiring strict federal registration and oversight.
Who it affects
- Chemical manufacturers and distributors
This notice was issued by the Drug Enforcement Administration; readers should consult the Federal Register for full technical details before relying on this information.
Agency: Justice Department, Drug Enforcement Administration
Source: Federal Register — read the official document